We collected information on 904 consecutive breast cancer patients treated with neoadjuvant chemotherapy at the European Institute of Oncology, Milan, Italy, between 1999 and 2011. The decrease of PgR and Ki-67 expression after preoperative chemotherapy has a prognostic role in breast cancer patients with residual disease.

Montagna, E., Bagnardi, V., Viale, G., Rotmensz, N., Sporchia, A., Cancello, G., et al. (2015). Changes in PgR and Ki-67 in residual tumour and outcome of breast cancer patients treated with neoadjuvant chemotherapy. ANNALS OF ONCOLOGY, 26(2), 307-313 [10.1093/annonc/mdu528].

Changes in PgR and Ki-67 in residual tumour and outcome of breast cancer patients treated with neoadjuvant chemotherapy

BAGNARDI, VINCENZO;
2015

Abstract

We collected information on 904 consecutive breast cancer patients treated with neoadjuvant chemotherapy at the European Institute of Oncology, Milan, Italy, between 1999 and 2011. The decrease of PgR and Ki-67 expression after preoperative chemotherapy has a prognostic role in breast cancer patients with residual disease.
Articolo in rivista - Articolo scientifico
HER2; breast cancer; chemotherapy; hormonal receptors; neoadjuvant therapy; surgery
English
2015
26
2
307
313
mdu528
none
Montagna, E., Bagnardi, V., Viale, G., Rotmensz, N., Sporchia, A., Cancello, G., et al. (2015). Changes in PgR and Ki-67 in residual tumour and outcome of breast cancer patients treated with neoadjuvant chemotherapy. ANNALS OF ONCOLOGY, 26(2), 307-313 [10.1093/annonc/mdu528].
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/65319
Citazioni
  • Scopus 41
  • ???jsp.display-item.citation.isi??? 44
Social impact